REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,610,803 | -2.9% | 158,615 | +18.0% | 0.00% | – |
Q2 2023 | $2,687,936 | -28.3% | 134,464 | -32.2% | 0.00% | – |
Q1 2023 | $3,748,907 | -0.4% | 198,250 | +19.4% | 0.00% | – |
Q4 2022 | $3,765,244 | +5.9% | 166,016 | +23.4% | 0.00% | – |
Q3 2022 | $3,554,000 | +43.5% | 134,499 | +34.1% | 0.00% | – |
Q2 2022 | $2,477,000 | -68.4% | 100,287 | -57.5% | 0.00% | -100.0% |
Q1 2022 | $7,840,000 | +95.0% | 236,194 | +92.1% | 0.00% | – |
Q4 2021 | $4,021,000 | +101.2% | 122,954 | +157.7% | 0.00% | – |
Q3 2021 | $1,999,000 | -9.0% | 47,708 | -15.6% | 0.00% | – |
Q2 2021 | $2,197,000 | -57.7% | 56,551 | -62.9% | 0.00% | -100.0% |
Q1 2021 | $5,197,000 | +44.8% | 152,360 | +92.6% | 0.00% | – |
Q4 2020 | $3,589,000 | +78.0% | 79,117 | +8.0% | 0.00% | – |
Q3 2020 | $2,016,000 | -55.4% | 73,271 | -40.4% | 0.00% | -100.0% |
Q2 2020 | $4,525,000 | +517.3% | 122,862 | +442.6% | 0.00% | – |
Q1 2020 | $733,000 | -79.3% | 22,642 | -73.8% | 0.00% | – |
Q4 2019 | $3,534,000 | +213.3% | 86,285 | +172.4% | 0.00% | – |
Q3 2019 | $1,128,000 | -79.7% | 31,672 | -70.8% | 0.00% | -100.0% |
Q2 2019 | $5,565,000 | -4.0% | 108,317 | +7.0% | 0.00% | 0.0% |
Q1 2019 | $5,799,000 | +99.6% | 101,191 | +46.1% | 0.00% | 0.0% |
Q4 2018 | $2,905,000 | -26.1% | 69,247 | +33.0% | 0.00% | 0.0% |
Q3 2018 | $3,931,000 | -16.8% | 52,064 | -20.9% | 0.00% | 0.0% |
Q2 2018 | $4,723,000 | +183.2% | 65,820 | +17.8% | 0.00% | – |
Q1 2018 | $1,668,000 | -61.2% | 55,882 | -56.8% | 0.00% | -100.0% |
Q4 2017 | $4,299,000 | +88.7% | 129,272 | +86.9% | 0.00% | – |
Q3 2017 | $2,278,000 | +118.6% | 69,148 | +31.0% | 0.00% | – |
Q2 2017 | $1,042,000 | +5.0% | 52,782 | +2.7% | 0.00% | – |
Q1 2017 | $992,000 | +5.3% | 51,380 | +1.2% | 0.00% | – |
Q4 2016 | $942,000 | +22.8% | 50,783 | -7.2% | 0.00% | – |
Q3 2016 | $767,000 | +421.8% | 54,738 | +198.2% | 0.00% | – |
Q2 2016 | $147,000 | +512.5% | 18,359 | +727.0% | 0.00% | – |
Q1 2016 | $24,000 | +50.0% | 2,220 | +133.7% | 0.00% | – |
Q4 2015 | $16,000 | +300.0% | 950 | +413.5% | 0.00% | – |
Q3 2015 | $4,000 | – | 185 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |